Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Volk

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neurobiology of Disease|December 24, 2016
Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophreniaDavid W Volk
Physiology & Behavior|January 16, 2003
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunctionDavid W Volk, David A Lewis
JAMA Psychiatry|June 6, 2019
Insights Into the Pathophysiology of Endocannabinoid Signaling in SchizophreniaDavid W Volk, David A Lewis
Current Topics in Behavioral Neurosciences|February 12, 2011
Prefrontal cortical circuits in schizophreniaDavid W Volk, David A Lewis
Biological Psychiatry|July 27, 2015
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in SchizophreniaDavid W Volk, David A Lewis
Schizophrenia Bulletin|July 24, 2014
Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophreniaDavid W Volk, David A Lewis
Current Neuropharmacology|May 1, 2012
GABA Targets for the Treatment of Cognitive Dysfunction in SchizophreniaDavid W Volk, David A Lewis
Biological Psychiatry|March 5, 2003
Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophreniaDavid W Volk, David A Lewis
Nature Reviews. Neuroscience|April 2, 2005
Cortical inhibitory neurons and schizophreniaDavid A Lewis, Takanori Hashimoto, David W Volk
Psychopharmacology|June 19, 2004
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunctionDavid A Lewis, David W Volk, Takanori Hashimoto
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neurobiology of Disease|December 24, 2016
Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophreniaDavid W Volk
Physiology & Behavior|January 16, 2003
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunctionDavid W Volk, David A Lewis
JAMA Psychiatry|June 6, 2019
Insights Into the Pathophysiology of Endocannabinoid Signaling in SchizophreniaDavid W Volk, David A Lewis
Current Topics in Behavioral Neurosciences|February 12, 2011
Prefrontal cortical circuits in schizophreniaDavid W Volk, David A Lewis
Biological Psychiatry|July 27, 2015
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in SchizophreniaDavid W Volk, David A Lewis
Schizophrenia Bulletin|July 24, 2014
Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophreniaDavid W Volk, David A Lewis
Current Neuropharmacology|May 1, 2012
GABA Targets for the Treatment of Cognitive Dysfunction in SchizophreniaDavid W Volk, David A Lewis
Biological Psychiatry|March 5, 2003
Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophreniaDavid W Volk, David A Lewis
Nature Reviews. Neuroscience|April 2, 2005
Cortical inhibitory neurons and schizophreniaDavid A Lewis, Takanori Hashimoto, David W Volk
Psychopharmacology|June 19, 2004
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunctionDavid A Lewis, David W Volk, Takanori Hashimoto
Pageof 4